Skip to main content
OpenTrials
Completed

NCT Number: NCT02745327

Nutrition, Overgrowth, and Vaccine Efficacy in Low-income Settings

The purpose of this study is to assess the impact of small intestine bacterial overgrowth (SIBO) on childhood nutritional status, growth, and oral vaccine efficacy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 day–7 day

Sex eligibility

All sexes

Study type

Observational

Primary location

The International Centre for Diarrhoeal Disease Research, Bangladesh

Dhaka, Bangladesh

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Child previously enrolled in the FIELD STUDIES protocol (enrollments in both studies may occur simultaneously)
  • Mother willing to sign informed consent form.
  • Healthy infant aged less than 7 days old

Exclusion criteria

  • Parents are not willing to have child's blood drawn, oral fluid collected, urine collected, or breath testing performed.
  • History of seizures, other apparent neurologic disorders, or other congenital abnormalities involving major organ systems.

Treatment and study plan

Primary outcomes

  1. Glucose-Hydrogen Breath Test

    Time frame: Birth to 2 years

    Test for Small Intestine Bacterial Overgrowth

Secondary outcomes

  1. Fecal Regenerating Islet-Derived 1 Beta (Reg 1B)

    Time frame: Birth to 2 years

  2. Fecal Myeloperoxidase

    Time frame: Birth to 2 years

  3. Serum 25-OH vitamin D

    Time frame: Birth to 2 years

  4. Serum Zinc

    Time frame: Birth to 2 years

  5. Serum Retinol Binding Protein

    Time frame: Birth to 2 years

  6. Serum Cobalamin

    Time frame: Birth to 2 years

  7. Serum Albumin

    Time frame: Birth to 2 years

  8. Lactulose mannitol ratio

    Time frame: 12 weeks of age

  9. Serum Tetanus antibody titers

    Time frame: Birth to 2 years

  10. Serum Polio antibody titers to sabin strains

    Time frame: Birth to 2 years

  11. Oral fluid Tetanus antibody titers

    Time frame: Birth to 2 years

  12. Height

    Time frame: Birth to 2 years

  13. Weight

    Time frame: Birth to 2 years

  14. Head circumference

    Time frame: Birth to 2 years

Sponsors and collaborators

Lead sponsor

University of Virginia

Other

Collaborators

  • International Centre for Diarrhoeal Disease Research, Bangladesh
  • Virginia Commonwealth University

Registry information

Official study title

A Longitudinal Study of Childhood Intestinal Bacterial Overgrowth, Vaccine Underperformance, and Malnutrition

Acronym: NOVEL

Important dates

Study start
2014
Primary completion
2018
Study completion
2018
First posted
Apr 20, 2016
Registry last updated
May 15, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.